En Es
Categories

FUJIREBIO

Fujirebio is a global leader in the field of IVD testing with more than 50 years’ experience in the conception, development, production and worldwide commercialization of robust IVD products. These span the range from specialized testing to fully automated routine clinical laboratory testing solutions covering a variet ...
Gold member
Products Covid-19Summary
Close

Covid-19 FUJIREBIO

Clinical Laboratory

Flu A/B & SARS-CoV-2 Real-Time RT-PCR Test
DiaPlexQ Flu A/B & SARS-CoV-2

DiaPlexQ Flu A/B & SARS-CoV-2 is a Real-time RT-PCR test for the qualitative detection of HA gene from Influenza A/B virus and N and ORF1a gene from SARS-CoV-2 in nasopharyngeal swab.
More details

SARS-CoV-2 (ORF1a, N, RdRp) Real-Time RT-PCR Test
DiaPlexQ SARS-CoV-2 (ORF1a, N, RdRp)

DiaPlexQ SARS-CoV-2 (ORF1a, N, RdRp) is a Real-time RT-PCR test for the qualitative detection of SARS-CoV-2 nucleic acids in various sample types.
More details

Automated Procalcitonin (PCT) Test
Lumipulse G B•R•A•H•M•S PCT

Lumipulse G B•R•A•H•M•S PCT immunoreaction cartridges are for in vitro diagnostic (IVD) use with a two-step sandwich immunoassay method on the LUMIPULSE G system for the quantitative determination of procalcitonin (PCT) in human serum and plasma. The CE marked test is the most sensitive fully automated PCT test and the assay utilizes proven CLEIA (chemiluminescent enzyme immunoassay) technology with results that in up to 35 minutes.
More details

COVID-19 Fluorescent RT-Isothermal Assay
iAMP COVID-19 SANO Assay

iAMP COVID-19 SANO Assay is a real-time fluorescent RT-isothermal assay based on Atila’s proprietary isothermal amplification technology. The CE marked assay is intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal swabs and saliva specimens from individuals with signs and symptoms of infection who are suspected of COVID-19.
More details

SARS-CoV-2 S-IgG Antibody Assay
Lumipulse G SARS-CoV-2 S-IgG

Lumipulse G SARS-CoV-2 S-IgG is an assay system, including a set of immunoassay reagents, for the quantitative measurement of IgG-type antibodies SARS-CoV-2 spike protein (SARS-CoV-2 S-IgG) in specimens based on CLEIA technology. The CE marked assay system has a specific two-step immunoassay method and runs on the LUMIPULSE G System with results available in up to 30 minutes.
More details

SARS-CoV-2 Antigen Test
Lumipulse G SARS-CoV-2 Ag

The CE marked Lumipulse G SARS-CoV-2 Ag is designed for in vitro diagnostic (IVD) use with the Lumipulse G system for the detection and quantitative measurement of SARS-CoV-2 antigen in human nasopharyngeal swab or saliva. The assay is meant to be used as a diagnostic tool for the confirmation of a SARS-CoV-2 infection and utilizes proven CLEIA (chemiluminescent enzyme immunoassay) technology with results available in up to 35 minutes.
More details

SARS-CoV-2 Ag Controls
Lumipulse® SARS-CoV-2 Ag Controls

The CE marked Lumipulse® SARS-CoV-2 Ag Controls are intended for use as an assayed quality control material to monitor the precision of laboratory testing procedures for the analysis of SARS-CoV-2 antigen on the LUMIPULSE G System.
More details

BNP Control
Lumipulse® BNP Control

The CE marked Lumipulse® BNP Control are intended for use as an assayed quality control to monitor the precision of laboratory testing procedures for the analysis of human B-type natriuretic peptide (BNP) on the LUMIPULSE G Systems.
More details

AMH Immunoreaction Cartridges
Lumipulse® G AMH (anti-Müllerian hormone)

The CE marked Lumipulse® G AMH (anti-Müllerian hormone) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the fully automated quantitative measurement of AMH in specimens based a two-step immunoassay method on the LUMIPULSE G System. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

LH Immunoreaction Cartridges
Lumipulse® G LH (Luteinizing Hormone)

The CE marked Lumipulse® G LH (Luteinizing Hormone) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of luteinizing hormone (LH) in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
More details

HIV p24 Antigen Test
INNOTEST® HIV Antigen mAb

The CE marked INNOTEST® HIV Antigen mAb is an enzyme immunoassay for the qualitative detection of HIV p24 antigen in human serum, plasma, and cell culture supernatant. The kit contains reagents for confirmation of HIV p24 antigens in repeatedly reactive samples.
More details

COVID-19 Test
iAMP COVID-19 Detection Kit

The CE marked iAMP COVID-19 Detection Kit is designed for the qualitative nucleic acid detection of SARS-CoV-2 (COVID-19) on naso- or oropharyngeal swabs without pre-treatment. Using isothermal amplification with real time fluorescence detection, the kit requires limited hands-on time and delivers fast sample-to-result within 75 to 90 minutes only.
More details

SARS-CoV-2 Assay
ESPLINE® SARS-CoV-2

The CE marked ESPLINE® SARS-CoV-2 is a cassette-style immunochromatographic assay for in vitro diagnostic (IVD) use for the detection of SARS-CoV-2 antigen directly from nasopharyngeal swab fluid. It can detect SARS-CoV-2 within 30 minutes using a simple procedure without any special instruments and is intended for use as an aid in the diagnosis of SARS-CoV-2 infection.
More details
Close

About FUJIREBIO

Fujirebio is a global leader in the field of IVD testing with more than 50 years’ experience in the conception, development, production and worldwide commercialization of robust IVD products. These span the range from specialized testing to fully automated routine clinical laboratory testing solutions covering a variety of disease states.
FaceBook Twitter Google+ Linked in
SARS-CoV-2 (ORF1a, N, RdRp) Real-Time RT-PCR Test

SARS-CoV-2 (ORF1a, N, RdRp) Real-Time RT-PCR Test

Model: DiaPlexQ SARS-CoV-2 (ORF1a, N, RdRp)
Request Information

Description:

DiaPlexQ SARS-CoV-2 (ORF1a, N, RdRp) is a Real-time RT-PCR test for the qualitative detection of SARS-CoV-2 nucleic acids in various sample types.

Features

Features

• Hot Start PCR: high specificity
• Detection Target: N and ORF1a genes
• OneStep PCR: multiple targets in a single reaction
• Reliable system: internal control RNase P
• Easy-to-use master mix: just adding template and Primer/Probe Mix
• Rapid detection: 75 minutes amplification
• Specimen Type: Nasopharyngeal, Oropharyngeal, Nasal, bronchoalveolar lavage (BAL) fluid, Sputum

Compatible instruments:
• Applied Biosystems 7500 Fast Real-Time PCR System
• Applied Biosystems 7500 Real-Time PCR System
• Bio-Rad CFX96 IVD Real-Time PCR System
• QuantStudio 5 Real-Time PCR System
• Adaptation to other thermal cyclers possible Request Information

Send A Message To This Supplier

* Required Information
* Email
To
FUJIREBIO (SARS-CoV-2 (ORF1a, N, RdRp) Real-Time RT-PCR Test)
* Message

Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions